SMITH MARK ALAN (CHIEF MEDICAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2021ACC: 0001415889-21-003388
Officer· CHIEF MEDICAL OFFICER
Since Aug 2018
+2.26K
Net shares
Net buyer
$4.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.26K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.26K
Price / share
$1.95
Trade value
$4.40K
% of position
22.6%
6/30/2021
10K→12.26K
Total
Net shares
+2.26K
Net value
$4.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2021 | A · Award | +2.26K | $1.95 | $4.40K | 22.6% | 10K | 12.26K |
| Total | +2.26K | $4.40K | ||||||
Derivative Transactions0
No derivative transactions reported